X-ray vendor Swissray International of Hitzkirch, Switzerland,has filed a 510(k) application with the Food and Drug Administrationfor its Add-On Bucky product, which uses charge-coupled device(CCD) technology to digitize x-rays. Swissray debuted the
X-ray vendor Swissray International of Hitzkirch, Switzerland,has filed a 510(k) application with the Food and Drug Administrationfor its Add-On Bucky product, which uses charge-coupled device(CCD) technology to digitize x-rays. Swissray debuted the deviceat the 1995 Radiological Society of North America meeting as aretrofit to existing x-ray systems (SCAN 12/13/95).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.